Benitec Biopharma Limited Sponsored ADR
(NASDAQ : BNTC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.46%91.111.3%$816.62m
AMGNAmgen Inc.
1.03%188.901.2%$647.11m
GILDGilead Sciences, Inc.
0.57%67.140.9%$518.97m
BIIBBiogen Inc.
0.31%334.021.3%$452.91m
ILMNIllumina, Inc.
-0.96%299.373.5%$320.86m
REGNRegeneron Pharmaceuticals, Inc.
-0.15%419.992.6%$310.18m
VRTXVertex Pharmaceuticals Incorporated
0.47%187.741.9%$272.96m
ALXNAlexion Pharmaceuticals, Inc.
0.56%129.652.0%$236.85m
SRPTSarepta Therapeutics, Inc.
0.66%141.1915.4%$159.34m
AAgilent Technologies, Inc.
0.67%78.041.6%$143.35m
EXASExact Sciences Corporation
-2.82%83.1625.3%$126.96m
INCYIncyte Corporation
-0.67%83.522.5%$115.78m
ARRYArray BioPharma Inc.
0.65%23.258.2%$111.19m
EXELExelixis, Inc.
-0.30%21.296.4%$84.28m
NBIXNeurocrine Biosciences, Inc.
-0.33%80.625.1%$82.37m

Company Profile

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. It operates through the Australia, and United States of America geographical segments. The company was founded in 1997 and is headquartered in North Sydney, Australia.